Beijing Anzhen Hospital
Clinical trials sponsored by Beijing Anzhen Hospital, explained in plain language.
-
New procedure zaps nerves to fix slow heartbeat
Disease control Recruiting nowThis study tests a procedure called cardioneuroablation, which uses a catheter to destroy specific heart nerves that cause an abnormally slow heartbeat. The goal is to improve heart rate and reduce symptoms like fainting or dizziness. About 188 adults aged 18-65 with symptomatic …
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
Heart procedure may fix leaky valves in AF patients
Disease control Recruiting nowThis study looks at whether a procedure called catheter ablation can help people with persistent atrial fibrillation (an irregular heartbeat) who also have severe mitral regurgitation (a leaky heart valve). The goal is to see if ablation reduces the leakiness better than medicati…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
Heart surgery in first month of life may give babies with rare defect a better future
Disease control Recruiting nowThis study tests whether operating within the first 28 days of life (neonatal repair) is safer and more effective than waiting until 3-6 months (infant repair) for babies born with Tetralogy of Fallot, a serious heart defect. About 160 full-term newborns weighing over 2.5 kg will…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 17, 2026 05:46 UTC
-
Sleep apnea breakthrough: CPAP plus sleep pill may slash blood pressure
Disease control Recruiting nowThis study looks at how well CPAP therapy lowers blood pressure in people with obstructive sleep apnea and high blood pressure. It also tests whether adding a mild sleep medication (trazodone or zolpidem) for those with insomnia can boost the blood pressure benefits. About 200 ad…
Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Heart patients may ditch daily blood thinners with smartwatch monitoring
Disease control Recruiting nowThis study looks at whether people with atrial fibrillation (AF) can safely stop taking blood thinners after a successful heart ablation procedure. About 4,100 adults who have been free of AF for at least 2 months after ablation will either stop or continue their blood thinner. E…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Heart procedure study tests best ECMO approach
Disease control Recruiting nowThis study compares two ways of using ECMO (a heart-lung support machine) during high-risk heart procedures. One group gets ECMO set up and ready to use if needed, while the other gets it started before the procedure. The goal is to see which approach leads to fewer serious probl…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
New combo device may cut stroke risk during artery stenting
Disease control Recruiting nowThis study compares two methods to protect the brain during a procedure to open a narrowed neck artery. About 296 people with significant artery narrowing will be randomly assigned to receive either the standard filter alone or a filter plus a balloon that temporarily stops blood…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Could a simple drug boost stroke recovery? new trial aims to find out.
Disease control Recruiting nowThis study tests whether giving the blood thinner tirofiban right after a clot-removal procedure helps people recover better from a severe stroke caused by hardened arteries. About 716 adults who have had a major stroke will be randomly assigned to receive either tirofiban or a p…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New heart pump combo aims to boost survival in shock patients
Disease control Recruiting nowThis study tests whether adding an intra-aortic balloon pump (IABP) early after starting a heart-lung machine (VA-ECMO) helps people in severe cardiogenic shock survive. About 358 adults will be randomly assigned to get the balloon pump or standard care. The main goal is to see i…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could a second clot drug boost stroke recovery?
Disease control Recruiting nowThis study tests whether adding a drug called tirofiban after standard clot-busting treatment helps people who had a stroke and aren't improving enough. About 976 adults will receive either tirofiban or a placebo for 24 hours, then standard care. The goal is to see if more people…
Phase: PHASE4 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Simple hydration may shield kidneys during heart ablation
Disease control Recruiting nowThis study tests whether giving extra fluids through an IV before and after a new type of heart procedure (pulsed field ablation) can prevent kidney injury in people with atrial fibrillation. About 290 adults will be randomly assigned to receive either standard care or extra flui…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Could stenting hidden heart plaques save lives? new trial aims to find out
Disease control Recruiting nowThis study tests whether placing stents in non-blocking but vulnerable plaques, along with intensive drug therapy, reduces heart-related events more than drugs alone. About 2,190 adults with acute coronary syndrome will be randomly assigned to one of two groups. The goal is to se…
Phase: PHASE4 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Digital tool aims to Fine-Tune heart failure drugs
Disease control Recruiting nowThis study tests whether a smartphone or web-based platform can help doctors adjust heart failure medications more effectively than usual care. About 252 adults with heart failure and reduced pumping function will be randomly assigned to use the digital tool or receive standard f…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New surgical technique aims to reduce death and stroke in aortic emergency
Disease control Recruiting nowThis study compares three surgical approaches for repairing a sudden tear in the main artery (acute type A aortic dissection) in 306 adults across 7 hospitals in China. The new method uses a clamp on the aortic arch under mild cooling, while the standard uses deeper cooling and a…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Heart surgeons test which bypass technique saves more lives in risky aneurysm repair
Disease control Recruiting nowThis study compares two ways of using a heart-lung machine during open surgery for a thoracoabdominal aortic aneurysm (a bulge in the main artery). 236 adults from 4 hospitals in China will be randomly assigned to one of two bypass methods. The goal is to see which technique lead…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
New heart catheter aims to fix irregular beats with less risk
Disease control Recruiting nowThis study looks at a new circular-shaped catheter that uses pulsed energy to treat atrial fibrillation and atrial flutter. It is guided by a special ultrasound inside the heart to improve accuracy. Researchers want to see if it can safely and effectively restore normal heart rhy…
Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
New heart scan could spare patients unnecessary procedures
Diagnosis Recruiting nowThis study tests whether a non-invasive heart scan called magnetocardiography (MCG) can help doctors decide the best treatment for people with stable coronary artery disease. About 1,300 participants will be split into two groups: one where treatment is guided by MCG results, and…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Diagnosis
Last updated May 17, 2026 05:32 UTC
-
No-Touch mattress could revolutionize heart monitoring in hospitals
Diagnosis Recruiting nowThis study is testing a special mattress that can check heart rate, breathing, temperature, and body position without touching the patient. It is designed for adults with heart disease who are staying in the hospital. The goal is to see if this smart mattress works as well as sta…
Sponsor: Beijing Anzhen Hospital • Aim: Diagnosis
Last updated May 12, 2026 13:43 UTC
-
Smartwatch study aims to stop heart disease before it starts
Prevention Recruiting nowThis study tests whether using a smart wearable device along with lifestyle coaching can improve heart health in 1,400 overweight or obese adults who have early signs of heart problems like high blood pressure or prediabetes. Participants will be tracked for 6 to 12 months to see…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Prevention
Last updated May 12, 2026 13:43 UTC
-
Heart procedure could boost wellbeing in elders with AF
Symptom relief Recruiting nowThis study looks at whether a procedure called catheter ablation can improve quality of life in people aged 80 and older who have atrial fibrillation (an irregular heartbeat). Participants will be randomly assigned to receive either the real procedure or a sham (fake) procedure. …
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
30,000 seniors enrolled in Decade-Long heart health experiment
Knowledge-focused Recruiting nowThis study is tracking 30,000 people aged 60 and older in rural China to see if a comprehensive program—combining medication, lifestyle advice, education, and heart monitoring—can lower the risk of heart attacks, strokes, and heart-related deaths. Participants will be followed fo…
Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 05:35 UTC
-
AI heart patch trial aims to prevent strokes in rural seniors
Knowledge-focused Recruiting nowThis study is testing whether a wearable, AI-enhanced heart monitor worn for 7 days can find more cases of atrial fibrillation (an irregular heartbeat that raises stroke risk) than usual care in people aged 60 and older living in rural China. About 15,360 participants from 128 vi…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC